Matinas BioPharma Holdings, Inc. SEC filings MTNB
Matinas BioPharma Holdings, Inc. has 570 filings in SEC EDGAR's recent list, going back to Jul 25, 2013. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B7 | Filing | Jun 22, 2026 | — |
| S-3 | Shelf registration | Jun 16, 2026 | — |
| S-8 | Employee stock plan registration | Jun 23, 2025 | — |
| 424B3 | Prospectus | Apr 29, 2025 | — |
| S-3 | Shelf registration | Apr 22, 2025 | — |
| 424B5 | Prospectus supplement | Apr 4, 2024 | — |
| 424B5 | Prospectus supplement | Jul 7, 2023 | — |
| S-3 | Shelf registration | Jun 9, 2023 | — |
| S-8 | Employee stock plan registration | Mar 31, 2023 | — |
| S-8 | Employee stock plan registration | Apr 1, 2022 | — |
| S-8 | Employee stock plan registration | Feb 26, 2021 | — |
| 424B5 | Prospectus supplement | Aug 10, 2020 | — |
| S-3/A | Filing | Jul 27, 2020 | — |
| S-3 | Shelf registration | Jul 2, 2020 | — |
| S-8 | Employee stock plan registration | Mar 20, 2020 | — |
| 424B5 | Prospectus supplement | Jan 13, 2020 | — |
| 424B5 | Prospectus supplement | Jan 9, 2020 | — |
| 424B5 | Prospectus supplement | Mar 18, 2019 | — |
| 424B5 | Prospectus supplement | Mar 14, 2019 | — |
| 424B5 | Prospectus supplement | Jun 19, 2018 | — |
| 424B5 | Prospectus supplement | Jun 19, 2018 | — |
| 424B5 | Prospectus supplement | May 25, 2018 | — |
| S-8 | Employee stock plan registration | Feb 7, 2018 | — |
| 424B5 | Prospectus supplement | Apr 28, 2017 | — |
| S-3 | Shelf registration | Apr 3, 2017 | — |
| S-8 | Employee stock plan registration | Jan 6, 2017 | — |
| 424B3 | Prospectus | Nov 22, 2016 | — |
| S-1/A | Amended registration statement | Nov 16, 2016 | — |
| S-1 | Registration statement | Nov 2, 2016 | — |
| 424B3 | Prospectus | May 16, 2016 | — |
| POS AM | Filing | Apr 22, 2016 | — |
| S-8 | Employee stock plan registration | Mar 30, 2016 | — |
| 424B3 | Prospectus | Jul 27, 2015 | — |
| S-1 | Registration statement | Jun 9, 2015 | — |
| 424B3 | Prospectus | May 11, 2015 | — |
| POS AM | Filing | Apr 17, 2015 | — |
| S-8 | Employee stock plan registration | Mar 31, 2015 | — |
| 424B3 | Prospectus | Dec 23, 2014 | — |
| S-8 | Employee stock plan registration | Aug 29, 2014 | — |
| 424B3 | Prospectus | May 22, 2014 | — |
| POS AM | Post-effective amendment no. 1 to form s-1 | May 14, 2014 | — |
| 424B3 | Prospectus | Feb 13, 2014 | — |
| S-1/A | Amended registration statement | Feb 11, 2014 | — |
| S-1/A | Amended registration statement | Feb 7, 2014 | — |
| S-1 | Registration statement | Jan 21, 2014 | — |
Showing 45 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MTNB (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Bedminster, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1582554
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.